COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 548: Articles 5471-5480  | Next

TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection
Metzdorf, K., Jacobsen, H., Greweling-Pils, M. C., Hoffmann, M., Lueddecke, T., Miller, F., Melcher, L., Kempf, A. M., Nehlmeier, I., Bruder, D., Widera, M., Ciesek, S., Poehlmann, S., Cicin-Sain, L.
10.1101/2022.12.09.519765 — Posted: 2022-12-09
Determinants for detection of infection with SARS-CoV-2 Omicron variants of concern in health care workers by rapid antigen tests
Knolle, P. A., Wettengel, J., Strehle, K., Lucke, C., Roggendorft, H., Jeske, S., Christa, C., Zelger, O., Haller, B., Protzer, U. A.
10.1101/2022.12.08.22283259 — Posted: 2022-12-09
Respiratory Virus Circulation during the First Year of the COVID-19 Pandemic in the Household Influenza Vaccine Evaluation (HIVE) Cohort
Fine, S. R., Bazzi, L. A., Callear, A. P., Petrie, J. G., Malosh, R. E., Tucker, J. E., Smith, M., Ibiebele, J., McDermott, A., Rolfes, M. A., Monto, A. S., Martin, E. T.
10.1101/2022.12.08.22283268 — Posted: 2022-12-09
Duration of viral shedding of the Omicron variant in asymptomatic and mild COVID-19 cases from Shanghai, China
Sun, W., Yang, N., Mao, Y., Yan, D., Song, Q., Qian, G.
10.1101/2022.12.08.22283272 — Posted: 2022-12-09
Mental health self-care during the COVID-19 pandemic: a prospective cohort study in Australia
Griffiths, D., Pradipta, V. M. K. D., Collie, A.
10.1101/2022.12.08.22283265 — Posted: 2022-12-09
Atlas-scale single-cell multi-sample multi-condition data integration using scMerge2
Lin, Y., Cao, Y., Willie, E., Patrick, E., Yang, J. Y. H.
10.1101/2022.12.08.519588 — Posted: 2022-12-08
Effect of BNT162b2 antigen dosage on protection against SARS-CoV-2 omicron infection
Chemaitelly, H., Ayoub, H., Coyle, P. V., Tang, P., YASSINE, H. M., Althani, A., Al-Khatib, H. A., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Al-Romaihi, H. E., Butt, A. A., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.11.29.22282864 — Posted: 2022-12-08
Sample average treatment effect on the treated analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
Mitra, A. K., Mukherjee, U. K., Mazumder, S., Madhira, V., Bergquist, T., Shao, Y. R., Liu, F., Song, Q., Su, J., Kumar, S., Bates, B. A., Sharafeldin, N., Topaloglu, U., on behalf of the National COVID Cohort Collaborative Consortium
10.1101/2022.12.07.22283208 — Posted: 2022-12-08
Mild SARS-CoV-2 infection results in long-lasting microbiota instability
Upadhyay, V., Suryawanshi, R., Tasoff, P., McCavitt-Malvido, M., Kumar, G. R., Murray, V., Noecker, C., Bisanz, J. E., Hswen, Y., Ha, C., Sreekumar, B., Chen, I. P., Lynch, S. V., Ott, M., Lee, S., Turnbaugh, P. J.
10.1101/2022.12.07.519508 — Posted: 2022-12-08
The Australian academic STEMM workplace post-COVID: a picture of disarray
Christian, K., Larkins, J.-a., Doran, M. R.
10.1101/2022.12.06.519378 — Posted: 2022-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).